Abstract: A material and method are described to reduce the non-specific binding of a labelled material, wherein the labelled material comprises a fluorochrome and a specific binding pair member. The invention is particularlly suited to the lysis of peripheral blood wherein a labelled material is used to identify and detect cell populations within a sample of blood.
Abstract: Monoclonal antibodies which recognize activated T lymphocytes are secreted by hybridomas produced by conventinal fusion and selection methodology following immunization of mice with a human lymphocyte fraction containing T lymphocytes activated by a mitrogen or an antigen. The monoclonal antibodies are used in a method to monitor subsets of activated T lymphocytes present, for example, from a patient's blood.
Abstract: Novel xanthene dyes are disclosed which excite in the range of 450-650 nm and which will emit to the red of fluoroscein. These dyes may be coupled to tagging agents, such as monoclonal antibodies, and used to detect cells in a sample.
Abstract: The invention relates to monoclonal antibodies against prosomal proteins of a prosome, said prosome having a sedimentation coefficient of approximately 19S, and to a method for detecting cancer using monoclonal antibodies specifically directed against said prosomal proteins. The invention also relates to diagnostic reagents for use in such a detection method.
Type:
Grant
Filed:
January 17, 1989
Date of Patent:
October 22, 1991
Assignee:
Pro-Soma
Inventors:
Klaus Scherrer, Maria-Fatima Grossi de Sa
Abstract: This invention provides a method of identifying mesenchymal tissues as normal, proliferatively active or malignant. This invention also provides a method of distinguishing subsets of sarcomas with distinctive antigenic phenotypes. This invention also provides a method of diagnosing mesenchymal tumors. Finally, this invention provides a monoclonal antibody designated G171 and the hybridoma cell line producing said monoclonal antibody (ATCC No. HB9254).
Type:
Grant
Filed:
May 2, 1988
Date of Patent:
October 22, 1991
Assignee:
Sloan-Kettering Institute for Cancer Research
Inventors:
Wolfgang J. Rettig, Pilar Garin-Chesa, H. Richard Beresford, Herbert F. Oettgen, Myron R. Melamed, Lloyd J. Old
Abstract: An image analysis system is used for the quantitation of nuclear proteins in cell populations. Particularly, the hormonal receptor content of fine needle aspirates of human breast carcinomas are evaluated. Estrogen or progesterone receptors are amplified and visualized in the specimen by a staining technique of the immunoperoxidase type. Monoclonal antibodies specific against the receptor are attached to the receptor sites and are then amplified by a bridging antibody which attaches to the monoclonal antibody and a peroxidase-antiperoxidase complex. A chromagen, diaminobenzidine is combined with the complex and treated with hydrogen peroxide to react with the peroxidase forming an insoluble brown precipitate which marks the receptor sites for optical identification. The specimen is then counterstained with another chromagen, methyl green which is specific to the nucleus of each cell.
Abstract: The present invention is an improved means for detecting neuroanatomical pathways in animals comprising introducing an atoxic fragment C of tetanus toxin into the motor target of a neural circuit, and permitting the atoxic fragment to transport through the neural circuitry. The fragment C of tetanus toxin is then localized along the neuroanatomical pathway by reacting the fragment C with monospecifically reactive antibody produced by a hybridoma cell line selected from the group consisting of .alpha.TTC-17, .alpha.TTC-44, .alpha.TTC-49 and .alpha.TTC-114. The present invention also includes the individual hybridoma cell lines which produce the reactive antibody along with the antibody themselves.
Type:
Grant
Filed:
October 6, 1988
Date of Patent:
April 2, 1991
Assignee:
The Research Foundation of State University of New York
Inventors:
Jonathan T. Erichsen, Craig Evinger, Harvey J. Karten